Philadelphia chromosome-positive B cell acute lymphoblastic phase arising 24 years after treatment-free remission for chronic myeloid leukemia with identical BCR-ABL fusion transcript

被引:0
|
作者
Dereme, Julien [1 ]
Voruz, Sophie [1 ]
Solly, Francoise [1 ]
Schoumans, Jacqueline [2 ,3 ]
Blum, Sabine [1 ,2 ]
机构
[1] Lausanne Univ Hosp CHUV, Serv & Cent Lab Haematol, Lausanne, Switzerland
[2] Lausanne Univ UNIL, Lausanne, Switzerland
[3] Lausanne Univ Hosp CHUV, Oncogen Lab, Lausanne, Switzerland
关键词
IMATINIB;
D O I
10.1007/s00277-023-05600-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1027 / 1029
页数:3
相关论文
共 50 条
  • [21] IMMUNOLOGICAL CHARACTERIZATION OF THE TUMOR-SPECIFIC BCR-ABL JUNCTION IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
    VANDENDEREN, J
    VANDERPLAS, D
    MEEUWSEN, T
    ZEGERS, N
    BOERSMA, W
    GROSVELD, G
    VANEWIJK, W
    BLOOD, 1990, 76 (01) : 136 - 141
  • [22] BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
    An, Xin
    Tiwari, Amit K.
    Sun, Yibo
    Ding, Pei-Rong
    Ashby, Charles R., Jr.
    Chen, Zhe-Sheng
    LEUKEMIA RESEARCH, 2010, 34 (10) : 1255 - 1268
  • [23] Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors
    Jones, Dan
    Thomas, Deborah
    Yin, C. Cameron
    O'Brien, Susan
    Cortes, Jorge E.
    Jabbour, Elias
    Breeden, Megan
    Giles, Francis J.
    Zhao, Weiqiang
    Kantarjian, Hagop M.
    CANCER, 2008, 113 (05) : 985 - 994
  • [24] A novel BCR-ABL1 mutation in a patient with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia
    Vinhas, Raquel
    Lourenco, Alexandra
    Santos, Susana
    Lemos, Marcos
    Ribeiro, Patricia
    de Sousa, Aida Botelho
    Baptista, Pedro Viana
    Fernandes, Alexandra Ramos
    ONCOTARGETS AND THERAPY, 2018, 11 : 8589 - 8598
  • [25] Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance
    Hantschel, Oliver
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (02): : 157 - 159
  • [26] Early Molecular Response (EMR) with Frontline Treatment Is a Significant Predictor of Long-Term BCR-ABL Transcript Levels in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML) in Chronic Phase
    Saglio, Giuseppe
    Snedecor, Sonya J.
    Ji, Xiang
    Tai, Ming-Hui
    Ray, David
    Mendelson, Estella
    Buchbinder, Aby
    Edrich, Pascal
    Mahon, Francois-Xavier
    BLOOD, 2015, 126 (23)
  • [27] Leptomycin B overcomes imatinib resistance mediated by stromal cells and mutant BCR-ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia cells.
    Tojo, A
    Izawa, K
    Sekine, R
    Nagamura, T
    Yoshida, M
    Tsuji, T
    BLOOD, 2004, 104 (11) : 575A - 575A
  • [28] A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
    Seymour, J. F.
    Kim, D. W.
    Rubin, E.
    Haregewoin, A.
    Clark, J.
    Watson, P.
    Hughes, T.
    Dufva, I.
    Jimenez, J. L.
    Mahon, F-X
    Rousselot, P.
    Cortes, J.
    Martinelli, G.
    Papayannidis, Cristina
    Nagler, A.
    Giles, F. J.
    BLOOD CANCER JOURNAL, 2014, 4 : e238 - e238
  • [29] A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
    J F Seymour
    D W Kim
    E Rubin
    A Haregewoin
    J Clark
    P Watson
    T Hughes
    I Dufva
    J L Jimenez
    F-X Mahon
    P Rousselot
    J Cortes
    G Martinelli
    C Papayannidis
    A Nagler
    F J Giles
    Blood Cancer Journal, 2014, 4 : e238 - e238
  • [30] Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia
    Kim, Theo D.
    Tuerkmen, Seval
    Schwarz, Michaela
    Koca, Goekben
    Nogai, Hendrik
    Bommer, Christiane
    Doerken, Bernd
    Daniel, Peter
    le Coutre, Philipp
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (04): : 582 - 588